Log in
OTCMKTS:QBIO

Q BioMed Stock Forecast, Price & News

$1.26
-0.05 (-3.82 %)
(As of 09/18/2020 08:10 PM ET)
Add
Compare
Today's Range
$1.22
Now: $1.26
$1.31
50-Day Range
$1.09
MA: $1.46
$1.87
52-Week Range
$0.34
Now: $1.26
$3.75
Volume31,228 shs
Average Volume113,791 shs
Market Capitalization$28.61 million
P/E RatioN/A
Dividend YieldN/A
Beta2.22
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; BM-001 for the treatment of rare pediatric nonverbal autism spectrum disorder; and Uttroside-B for liver cancer. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:QBIO
Previous SymbolNASDAQ:QBIO
CUSIPN/A
Phone212-588-0022

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.26) per share

Profitability

Net Income$-10,280,000.00

Miscellaneous

Employees1
Market Cap$28.61 million
Next Earnings Date10/20/2020 (Estimated)
OptionableNot Optionable
$1.26
-0.05 (-3.82 %)
(As of 09/18/2020 08:10 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

How has Q BioMed's stock price been impacted by COVID-19 (Coronavirus)?

Q BioMed's stock was trading at $1.5728 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, QBIO stock has decreased by 19.9% and is now trading at $1.26.
View which stocks have been most impacted by COVID-19
.

When is Q BioMed's next earnings date?

Q BioMed is scheduled to release its next quarterly earnings announcement on Tuesday, October 20th 2020.
View our earnings forecast for Q BioMed
.

How were Q BioMed's earnings last quarter?

Q BioMed Inc (OTCMKTS:QBIO) announced its quarterly earnings results on Wednesday, July, 15th. The company reported ($0.11) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.13) by $0.02. The company had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.49 million.
View Q BioMed's earnings history
.

Who are some of Q BioMed's key competitors?

What other stocks do shareholders of Q BioMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Q BioMed investors own include Micron Technology (MU), NVIDIA (NVDA), Washington Trust Bancorp (WASH), Nokia Oyj (NOK), Canopy Growth (CGC), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Opko Health (OPK), AT&T (T) and Advanced Micro Devices (AMD).

Who are Q BioMed's key executives?

Q BioMed's management team includes the following people:
  • Mr. Denis D. Corin, Chairman, CEO, Pres & CFO (Age 46)
  • Mr. William S. Rosenstadt, Gen. Counsel & Director (Age 51)
  • Mr. David Laskow-Pooley, VP of Product Devel. (Age 65)
  • Mr. Robert Derham, VP of Orphan Products
  • Mr. Ari Jatwes, Bus. Devel. Analyst

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $1.26.

How big of a company is Q BioMed?

Q BioMed has a market capitalization of $28.61 million. The company earns $-10,280,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis. Q BioMed employs 1 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is www.qbiomed.com.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at 212-588-0022.

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.